(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ YES ☐ NO

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ YES ☐ NO

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): YES ☐ NO ☒

As of ~~November 4, 2019,~~May 8, 2020, the registrant had ~~11,536,140~~11,598,015 shares of common stock outstanding.

Unless otherwise indicated or required by the context, all references in this Quarterly Report on Form 10-Q to “we,” “us,” “our,” “red violet,” or the “Company,” refer to Red Violet, Inc. and its consolidated subsidiaries.

	September 30, 2019			December 31, 2018			March 31, 2020			December 31, 2019
ASSETS:
Current assets:
Cash and cash equivalents	$	13,337		$	9,950		$	11,454		$	11,776
Accounts receivable, net of allowance for doubtful accounts of $30 and $77 as of September 30, 2019 and December 31, 2018, respectively		3,325			2,265
Accounts receivable, net of allowance for doubtful accounts of $19 and $40 as of March 31, 2020 and December 31, 2019, respectively								3,039			3,543
Prepaid expenses and other current assets		894			934			1,116			722
Total current assets		17,556			13,149			15,609			16,041
Property and equipment, net		704			852			616			660
Intangible assets, net		23,050			19,971			25,310			24,034
Goodwill		5,227			5,227			5,227			5,227
Right-of-use assets		2,729			-			2,509			2,620
Other noncurrent assets		374			628			226			289
Total assets	$	49,640		$	39,827		$	49,497		$	48,871
LIABILITIES AND SHAREHOLDERS' EQUITY:
Current liabilities:
Accounts payable	$	2,481		$	2,246		$	2,229		$	2,138
Accrued expenses and other current liabilities		2,004			1,277			816			1,571
Current portion of operating lease liabilities		477			-			506			491
Deferred revenue		35			26			207			128
Total current liabilities		4,997			3,549			3,758			4,328
Noncurrent operating lease liabilities		2,588			-			2,327			2,459
Total liabilities		7,585			3,549			6,085			6,787
Shareholders' equity:
Preferred stock—$0.001 par value, 10,000,000 shares authorized, and 0 shares issued and outstanding, as of September 30, 2019 and December 31, 2018		-			-
Common stock—$0.001 par value, 200,000,000 shares authorized, 11,633,662 and 10,266,613 shares issued, 11,530,515 and 10,266,613 shares outstanding, as of September 30, 2019 and December 31, 2018		12			10
Treasury stock, at cost, 103,147 and 0 shares as of September 30, 2019 and December 31, 2018		(1,255	)		-
Preferred stock—$0.001 par value, 10,000,000 shares authorized, and 0 shares issued and outstanding, as of March 31, 2020 and December 31, 2019								-			-
Common stock—$0.001 par value, 200,000,000 shares authorized, 11,693,162 and 11,657,912 shares issued, 11,590,015 and 11,554,765 shares outstanding, as of March 31, 2020 and December 31, 2019								12			12
Treasury stock, at cost, 103,147 shares as of March 31, 2020 and December 31, 2019								(1,255	)		(1,255	)
Additional paid-in capital		54,302			41,052			61,996			59,187
Accumulated deficit		(11,004	)		(4,784	)		(17,341	)		(15,860	)
Total shareholders' equity		42,055			36,278			43,412			42,084
Total liabilities and shareholders' equity	$	49,640		$	39,827		$	49,497		$	48,871

	Three Months Ended September 30,						Nine Months Ended September 30,						Three Months Ended March 31,
	2019			2018			2019			2018			2020			2019
Revenue	$	8,257		$	4,360		$	21,236		$	11,594		$	9,300		$	5,734
Costs and expenses:
Cost of revenue (exclusive of depreciation and amortization)		3,122			2,233			8,843			6,334			3,292			2,669
Sales and marketing expenses		1,925			1,126			5,428			3,443			2,176			1,500
General and administrative expenses		3,498			2,182			11,259			5,776			4,434			2,365
Depreciation and amortization		750			508			2,049			1,437			910			618
Total costs and expenses		9,295			6,049			27,579			16,990			10,812			7,152
Loss from operations		(1,038	)		(1,689	)		(6,343	)		(5,396	)		(1,512	)		(1,418	)
Interest income, net		46			31			123			31			31			40
Other income, net		-			406			-			535
Loss before income taxes		(992	)		(1,252	)		(6,220	)		(4,830	)		(1,481	)		(1,378	)
Income taxes		-			-			-			-			-			-
Net loss	$	(992	)	$	(1,252	)	$	(6,220	)	$	(4,830	)	$	(1,481	)	$	(1,378	)
Loss per share:
Basic and diluted	$	(0.09	)	$	(0.12	)	$	(0.59	)	$	(0.47	)	$	(0.13	)	$	(0.13	)
Weighted average number of shares outstanding:
Basic and diluted		10,917,673			10,266,613			10,497,036			10,266,613			11,583,214			10,267,680

Common stock

Treasury stock

Additional paid-in

Accumulated

Member's

Shares

Amount

Shares

Amount

capital

deficit

capital

Total

Balance at June 30, 2019

10,286,613

$
10

-

$
-

$
45,253

$
(10,012
)

$
-

$
35,251

Vesting of restricted stock units

666,049

1

-

-

(1
)

-

-

-

Increase in treasury stock resulting
  from shares withheld to cover
  statutory taxes

-

-

103,147

(1,255
)

-

-

-

(1,255
)
Issuance of common stock upon direct
  offering to certain investors, net of
  issuance costs of $55

681,000

1

-

-

7,435

-

-

7,436

Share-based compensation

-

-

-

-

1,615

-

-

1,615

Net loss

-

-

-

-

-

(992
)

-

(992
)
Balance at September 30, 2019

11,633,662

$
12

103,147

$
(1,255
)

$
54,302

$
(11,004
)

$
-

$
42,055

Balance at June 30, 2018

10,266,613

$
10

-

$
-

$
40,301

$
(1,494
)

$
-

$
38,817

Share-based compensation

-

-

-

-

353

-

-

353

Net loss

-

-

-

-

-

(1,252
)

-

(1,252
)
Balance at September 30, 2018

10,266,613

$
10

-

$
-

$
40,654

$
(2,746
)

$
-

$
37,918

Common stock

Treasury stock

Additional paid-in

Accumulated

Member's

Shares

Amount

Shares

Amount

capital

deficit

capital

Total

Balance at December 31, 2018

10,266,613

$
10

-

$
-

$
41,052

$
(4,784
)

$
-

$
36,278

Vesting of restricted stock units

686,049

1

-

-

(1
)

-

-

-

Increase in treasury stock resulting
  from shares withheld to cover
  statutory taxes

-

-

103,147

(1,255
)

-

-

-

(1,255
)
Issuance of common stock upon direct
  offering to certain investors, net of
  issuance costs of $55

681,000

1

-

-

7,435

-

-

7,436

Share-based compensation

-

-

-

-

5,816

-

-

5,816

Net loss

-

-

-

-

-

(6,220
)

-

(6,220
)
Balance at September 30, 2019

11,633,662

$
12

103,147

$
(1,255
)

$
54,302

$
(11,004
)

$
-

$
42,055

Balance at December 31, 2017

1,000

$
-

-

$
-

$
-

$
-

$
17,736

$
17,736

Contribution by Fluent, Inc., including
  allocation of expenses

-

-

-

-

-

-

24,264

24,264

Share-based compensation

-

-

-

-

402

-

346

748

Net loss

-

-

-

-

-

(2,746
)

(2,084
)

(4,830
)
Spin-off from Fluent, Inc.

10,265,613

10

-

-

40,252

-

(40,262
)

-

Balance at September 30, 2018

10,266,613

$
10

-

$
-

$
40,654

$
(2,746
)

$
-

$
37,918

	Common stock				Treasury stock						Additional paid-in		Accumulated
	Shares		Amount		Shares			Amount			capital		deficit			Total
Balance at December 31, 2018		10,266,613	$	10		-		$	-		$	41,052	$	(4,784	)	$	36,278
Vesting of restricted stock units		20,000		-		-			-			-		-			-
Share-based compensation		-		-		-			-			424		-			424
Net loss		-		-		-			-			-		(1,378	)		(1,378	)
Balance at March 31, 2019		10,286,613	$	10		-		$	-		$	41,476	$	(6,162	)	$	35,324

Balance at December 31, 2019		11,657,912	$	12		(103,147	)	$	(1,255	)	$	59,187	$	(15,860	)	$	42,084
Vesting of restricted stock units		35,250		-		-			-			-		-			-
Share-based compensation		-		-		-			-			2,809		-			2,809
Net loss		-		-		-			-			-		(1,481	)		(1,481	)
Balance at March 31, 2020		11,693,162	$	12		(103,147	)	$	(1,255	)	$	61,996	$	(17,341	)	$	43,412

	Nine Months Ended September 30,						Three Months Ended March 31,
	2019			2018			2020			2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(6,220	)	$	(4,830	)	$	(1,481	)	$	(1,378	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization		2,049			1,437			910			618
Share-based compensation expense		5,290			432			2,221			274
Write-off of long-lived assets		30			63			17			30
Provision for bad debts		398			246			190			154
Allocation of expenses from Fluent, Inc.		-			325
Noncash lease expenses		313			-			111			103
Changes in assets and liabilities:
Accounts receivable		(1,458	)		(781	)		314			(677	)
Prepaid expenses and other current assets		40			(177	)		(394	)		(359	)
Other noncurrent assets		254			167			63			85
Accounts payable		235			(55	)		91			(97	)
Accrued expenses and other current liabilities		(183	)		(3,619	)		(755	)		143
Deferred revenue		9			(18	)		79			23
Operating lease liabilities		(322	)		-			(117	)		(105	)
Net cash provided by (used in) operating activities		435			(6,810	)		1,249			(1,186	)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment		(71	)		(51	)		(33	)		(15	)
Capitalized costs included in intangible assets		(4,413	)		(4,497	)		(1,538	)		(1,430	)
Net cash used in investing activities		(4,484	)		(4,548	)		(1,571	)		(1,445	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Capital contributed by Fluent, Inc.		-			23,939
Proceeds from issuance of shares, net of issuance costs		7,436			-
Net cash provided by financing activities		7,436			23,939
Net increase in cash and cash equivalents	$	3,387		$	12,581
Net decrease in cash and cash equivalents							$	(322	)	$	(2,631	)
Cash and cash equivalents at beginning of period		9,950			65			11,776			9,950
Cash and cash equivalents at end of period	$	13,337		$	12,646		$	11,454		$	7,319
SUPPLEMENTAL DISCLOSURE INFORMATION
Cash paid for interest	$	-		$	-		$	-		$	-
Cash paid for income taxes	$	-		$	-		$	-		$	-
Share-based compensation capitalized in intangible assets	$	526		$	316		$	588		$	150
Right-of-use assets obtained in exchange of operating lease liabilities	$	3,042		$	-		$	-		$	3,042
Operating lease liabilities arising from obtaining right-of-use assets	$	3,387		$	-		$	-		$	3,387

The accompanying unaudited condensed consolidated financial statements of Red Violet, Inc. (“red violet” or the “Company”), a Delaware corporation, have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) and applicable rules and regulations of the Securities and Exchange Commission regarding interim financial reporting. Certain information and note disclosures normally included in annual financial statements prepared in accordance with US GAAP have been condensed or omitted pursuant to those rules and regulations.

~~On March 26, 2018, Fluent, Inc. (“Fluent”) completed a spin-off of its risk management business from its digital marketing business by way of a distribution of all the shares of~~ common stock of Fluent’s then wholly-owned subsidiary, red violet, to Fluent’s stockholders of record as of March 19, 2018, the record date, and certain warrant holders (the “Spin-off”). The distribution occurred by way of a pro rata stock distribution to such common stock and warrant holders, each of whom received one share of red violet’s common stock for every 7.5 shares of Fluent’s common stock held on the record date or to which they were entitled to under their warrants, which resulted in a distribution of a total of 10,266,613 shares of red violet common stock. ~~Upon the Spin-off, the Company owns FluentsubsidiariesthatpreviouslyoperatedFluent’sriskmanag~~e~~mentbusiness. The Company accounted for the Spin-off in accordance with ASC 805-50-30-5~~ ~~Initial Measurement- Transactions Between Entities Under Common Control~~ – ~~Transfer Date Measurement~~ and therefore the net assets transferred from Fluent to red violet upon the Spin-off were reflected in red violet’s condensed consolidated financial statements at Fluent’s carrying values at the time of the Spin-off.

The accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for any future interim periods or for the full year ending December 31, ~~2019.~~2020.

The information included in this quarterly report on Form 10-Q should be read in conjunction with the consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2018~~2019 (“~~2018~~2019 Form 10-K”).

The condensed consolidated balance sheet as of December 31, ~~2018~~2019 included herein was derived from the audited financial statements as of that date included in the ~~2018~~2019 Form 10-K, but does not include all disclosures required by US GAAP.

The Company has only 1 operating segment, as defined by Accounting Standards Codification (“ASC”) 280, “Segment Reporting.”

The condensed consolidated financial statements include the financial statements of the Company and its subsidiaries. All significant transactions among the Company and its subsidiaries have been eliminated upon ~~consolidation.~~ consolidation~~For periods prior to the Spin-off, these financial statements were prepared on a consolidated and combined basis because certain of the entities were under common control.~~.

Although the Spin-off was completed on March 26, 2018, the Company has reflected the Spin-off in these financial statements as if it occurred on March 31, 2018 as the Company determined that the impact is not material to the condensed consolidated financial statements.

The historical condensed consolidated and combined financial results presented prior to the Spin-off may not be indicative of the results that would have been achieved by the Company had it operated as a separate, standalone entity prior to the Spin-off. The condensed consolidated and combined financial statements presented prior to the Spin-off do not reflect any changes that may occur in the Company’s operations in connection with or as a result of the Spin-off.

As an emerging growth company, the Company has left open the opportunity to take advantage of the extended transition period provided to emerging growth companies in Section 13(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), however, it is the Company’s present intention to adopt any applicable new accounting standards timely.

In February 2016, Financial Accounting Standard Board (“FASB”) issued ASU No. 2016-02 (“ASU 2016-02”), “Leases (Topic 842),” which generally requires companies to recognize operating and financing lease liabilities and corresponding right-of-use assets on the balance sheet. In July 2018, FASB issued ASU No. 2018-10, “Codification Improvements to Topic 842, Leases,” and ASU No. 2018-11, “Leases (Topic 842): Targeted Improvements.” Topic 842 is effective for public entities and private entities in the first quarter of 2019 and the first quarter of 2020, respectively, on a modified retrospective basis. The Company adopted Topic 842 in the first quarter of 2019. The Company recorded a right-of-use asset and a total operating lease obligation on its condensed consolidated balance sheet of approximately $3.0 million and $3.4 million, respectively, upon the adoption. Refer to Note 10, Leases, for further details.

In June 2016, FASB issued ASU No. 2016-13 (“ASU 2016-13”), ~~“Financial~~“Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” In November 2018, FASB issued ASU No. 2018-19, “Codification Improvements to Topic 326, Financial Instruments-Credit Losses,” which amends the scope and transition requirements of ASU 2016-13. Topic 326 requires a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions and reasonable and supportable forecasts that affect the collectability of the reported amount. Topic 326 ~~will become~~became effective for public companies beginning January 1, 2020, ~~with early adoption permitted,~~and the Company adopted it on a modified retrospective approach. The ~~Company is currently evaluating~~guidance had no material impact on the ~~impact this guidance will have on its~~Company’s condensed consolidated financial statements and related disclosures.

In August 2018, FASB issued ASU No. 2018-15 (“ASU 2018-15”), ~~“Intangibles—~~“Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract,” which requires an entity (customer) in a hosting arrangement that is a service contract to follow the guidance in Subtopic 350-40 to determine which implementation costs to capitalize as an asset related to the service contract and which costs to expense. It also requires the entity (customer) to expense the capitalized implementation costs of a hosting arrangement that is a service contract over the term of the hosting arrangement, which includes reasonably certain renewals. This guidance will be effective for the Company for annual reporting periods beginning after December 15, 2020, on a retrospective or prospective basis and early adoption is permitted. The Company is currently evaluating the impact this guidance will have on its consolidated financial statements and related disclosures.

Basic loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the periods. Diluted loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock and is calculated using the treasury stock method for unvested shares. Common equivalent shares are excluded from the calculation in the loss periods as their effects would be anti-dilutive.

Prior to the Spin-off, the financial information of red violet represented the consolidated and combined figures of red violet and its subsidiaries. red violet only had 1,000 shares of common stock outstanding, all of which Fluent owned. On March 26, 2018, upon the Spin-off of red violet, an aggregate of 10,266,613 shares of red violet common stock were distributed to Fluent stockholders and certain warrant holders. This number of shares remained outstanding as of September 30, 2018 and is utilized to calculate loss per share for the nine months ended September 30, 2018, as shown in the table below.

A total of 1,954,910 unvested restricted stock units (“RSUs”) have been excluded from the diluted loss per share for the three and nine months ended September 30, 2019, and 2,145,500 RSUs have been excluded for the three and nine months ended September 30, 2018, as the impact is anti-dilutive.

The gross amount associated with software developed for internal use represents capitalized costs of internally-developed software, including eligible salaries and staff benefits, ~~and~~ share-based compensation, travel expenses incurred by relevant employees, and other relevant costs.

Amortization expenses of ~~$689~~$850 and ~~$445~~$554 for the three months ended ~~September 30,~~March 31, 2020 and 2019, ~~and 2018, respectively, and $1,860 and $1,235 for the nine months ended September 30, 2019 and 2018,~~ respectively, were included in depreciation and amortization expense. As of ~~September 30, 2019,~~March 31, 2020, intangible assets of ~~$4,018,~~$4,136, included in the gross amounts of software developed for internal use, have not started amortization, as they are not ready for their intended use.

The Company capitalized costs of ~~internally-developed~~ software developed for internal use of ~~$1,708~~$2,126 and ~~$1,744~~$1,580 during the three months ended ~~September 30,~~March 31, 2020 and 2019, ~~and 2018, respectively, and $4,939 and $4,813 for the nine months ended September 30, 2019 and 2018,~~ respectively.

As of ~~September 30, 2019,~~March 31, 2020, estimated amortization expense related to the Company’s intangible assets for the remainder of ~~2019~~2020 through ~~2024~~2025 and thereafter are as follows:

Goodwill represents the cost in excess of the fair value of the net assets acquired in a business combination. As of ~~September 30, 2019~~March 31, 2020 and December 31, ~~2018,~~2019, the balance of goodwill of $5,227 was as a result of the acquisition of Interactive Data, LLC, a wholly-owned subsidiary of red violet, effective on October 2, 2014.

In accordance with ASC 350, “Intangibles - Goodwill and Other,” goodwill is tested at least annually for impairment, or when events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable, by assessing qualitative factors or performing a quantitative analysis in determining whether it is more likely than not that its fair value exceeds the carrying value. The measurement date of the Company’s annual goodwill impairment test is October 1.

As of ~~September 30, 2019~~March 31, 2020 and December 31, ~~2018,~~2019, 0 goodwill impairment charges were recorded.

On January 1, 2018, the Company adopted ASC 606, ~~“Revenue~~“Revenue from Contracts with Customers,” (“Topic 606”) using the modiﬁed retrospective method applied to all contracts that were not completed contracts at the date of initial application. ~~There was no impact on the opening accumulated deﬁcit as of January 1, 2018 due to the adoption of Topic 606.~~ Revenue is recognized when control of goods or services is transferred to the Company’s customers, in an amount that reﬂects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company’s performance obligation is to provide on demand solutions to its customers by leveraging its proprietary technology and applying machine learning and advanced analytics to its massive data repository. The pricing for the customer contracts is based on usage, a monthly fee, or a combination of both.

Available within Topic 606, the Company has applied the portfolio approach practical expedient in accounting for customer revenue as one collective group, rather than individual contracts. Based on the Company’s historical knowledge of the contracts contained in this portfolio and the similar nature and characteristics of the customers, the Company has concluded the financial statement effects are not materially different than if accounting for revenue on a contract by contract basis.

Revenue is recognized over a period of time since the performance obligation is delivered in a series. The Company’s customers simultaneously receive and consume the benefits provided by the Company’s performance as and when provided. Furthermore, the Company has elected the “right to invoice” practical expedient, available within Topic 606, as its measure of progress, since it has a right to payment from a customer in an amount that corresponds directly with the value of its performance completed-to-date. The Company's revenue arrangements do not contain significant financing components.

For the three months ended ~~September 30,~~March 31, 2020 and 2019, 69% and ~~2018, 66% and 64%~~67% of total revenue was attributable to customers with pricing contracts, respectively, versus ~~34%~~31% and 36% attributable to transactional customers, respectively. For the nine months ended September 30, 2019 and 2018, 65% and 54% of total revenue was attributable to customers with pricing contracts, respectively, versus 35% and 46%33% attributable to transactional customers, respectively. Pricing contracts are generally annual contracts or longer, with auto renewal.

If a customer pays consideration before the Company transfers services to the customer, those amounts are classiﬁed as deferred revenue. As of ~~September 30, 2019~~March 31, 2020 and December 31, ~~2018,~~2019, the balance of deferred revenue was ~~$35~~$207 and ~~$26,~~$128, respectively, all of which is expected to be realized in the next 12 months. In relation to the deferred revenue balance as of December 31, ~~2018, $0 and $26~~2019, $91 was recognized into revenue during the three ~~and nine~~ months ended ~~September 30, 2019, respectively.~~March 31, 2020.

As of ~~September 30, 2019, $3,405~~March 31, 2020, $3,868 of revenue is expected to be recognized in the future for outstanding performance obligations, primarily related to pricing contracts that have a term of more than 12 months. ~~$522~~$1,967 of revenue will be recognized in the remainder of ~~2019, $1,795 in~~ 2020, ~~$1,085~~$1,820 in 2021, $65 in 2022, and $3$16 in ~~2022.~~2023 and thereafter. The actual timing of recognition may vary due to factors outside of the Company’s control. The Company excludes variable consideration related entirely to wholly unsatisfied performance obligations and contracts and recognizes such variable consideration based upon the right to invoice the customer.

Sales commissions are incurred and recorded on an ongoing basis over the term of the customer relationship. These costs are recorded in sales and marketing expenses.

In addition, the Company elected the practical expedient to not disclose the value of unsatisﬁed performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which the Company recognizes revenue at the amount to which it has the right to invoice for services performed.

The Company is subject to federal and state income taxes in the United States. The Company’s tax provision for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items arising in that quarter. In each quarter, the Company updates its estimate of the annual effective tax rate, and if its estimated annual tax rate changes, the Company makes a cumulative adjustment in that quarter.

red violet is a “C” corporation, while its subsidiaries are all limited liability companies. Before the Spin-off, red violet and its subsidiaries were consolidated with Fluent for U.S. federal income tax purposes. However, for purposes of these financial statements, the income tax provisions prior to the Spin-off were prepared assuming the entities filed separate tax returns.

The Company’s effective income tax rate differed from the statutory federal income tax rate of ~~21%~~21% for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2020 and 2019 ~~and 2018~~. For the three ~~and nine~~ months ended ~~September 30,~~March 31, 2020 and 2019, ~~and 2018,~~ the effective income tax rate was 0%, and the difference is primarily the result of the full valuation allowance applied against the Company’s deferred tax assets.

The Company assesses its income tax positions and records tax benefits for all years subject to examination based upon its evaluation of the facts, circumstances and information available at the reporting date. For those tax positions where it is more-likely-than-not that a tax benefit will be sustained, the Company has recorded the largest amount of tax benefit with a greater than 50% likelihood of being realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where it is not more-likely-than-not that a tax benefit will be sustained, 0 tax benefit has been recognized in the Company’s financial statements.

The Company continually evaluates expiring statutes of limitations, audits, proposed settlements, changes in tax law and new authoritative rulings. All of the Company’s income tax filings since ~~2015~~2016 remain open for tax examinations.

The Company does 0t have any unrecognized tax benefits as of ~~September 30, 2019~~March 31, 2020 and December 31, ~~2018.~~2019.

As of ~~September 30, 2019~~March 31, 2020 and December 31, ~~2018,~~2019, the number of issued shares of common stock was ~~11,633,662~~11,693,162 and ~~10,266,613,~~11,657,912, respectively, which included shares of treasury stock of ~~103,417~~103,147 and 0,103,147, respectively. The change in the number of issued shares of common stock was due to an aggregate of 35,250 shares of common stock issued as a result of the ~~following issuance:~~vesting of RSUs.

As of ~~September 30,~~March 31, 2020 and December 31, 2019, the Company held 103,147 shares of treasury stock, with a cost of ~~$1,255. There was 0 treasury stock~~$1,255, as a result of ~~December 31, 2018. This increase in treasury stock was due to~~the shares withheld to pay withholding taxes upon the vesting of RSUs.

On March 22, 2018, the board of directors of the Company and Fluent, Inc., in its capacity as sole stockholder of ~~red violet prior to~~ the ~~Spin-off,~~Company at that time, approved the Red Violet, Inc. 2018 Stock Incentive Plan (the “2018 Plan”)~~, which became effective immediately prior to the Spin-off.~~. A total of 3,000,000 shares of common stock were authorized to be issued under the 2018 Plan. The primary purpose of the 2018 Plan is to attract, retain, reward and motivate certain individuals by providing them with an opportunity to acquire or increase a proprietary interest in the Company and to incentivize them to expend maximum effort for the growth and success of the Company, so as to strengthen the mutuality of the interests between such individuals and the stockholders of the Company.

As of ~~September 30, 2019,~~March 31, 2020, there were ~~346,791~~44,624 shares of common stock ~~reserved~~available for future issuance under the 2018 Plan.

On April 17, 2020, the board of directors of the Company approved, subject to stockholder approval, an amendment to the 2018 Plan to increase the number of shares of common stock authorized for issuance under the 2018 ~~Plan.~~Plan from 3,000,000 shares to 4,500,000 shares.

Details of unvested RSU activity during the ~~nine~~three months ended ~~September 30, 2019~~March 31, 2020 were as follows:

As a result of meeting the 2018 Performance Criteria as of June 30, 2019, the Company recognized a total of ~~$1,075 and~~$971 ~~$4,489~~ of share-based compensation expense relating to RSUs with the 2018 Performance Criteria for the three months ended March 31, 2020. No share-based compensation expense of such RSUs was recognized during the three ~~and nine~~ months ended ~~September 30,~~March 31, 2019 ~~respectively. Of the $4,489 recognized, $1,309 represented a catch-up of unamortized expense from September 5, 2018 through December 31, 2018, which was not recognized in prior periods~~ because the Company determined at ~~each~~that period end that it was not probable that the 2018 Performance Criteria would be met.

As of ~~September 30, 2019,~~March 31, 2020, unrecognized share-based compensation expense associated with the granted RSUs amounted to ~~$15,105,~~$12,654, which is expected to be recognized over a remaining weighted average period of ~~2.3~~2.0 years.

Share-based compensation was allocated to the following accounts in the condensed consolidated financial statements for the three ~~and nine~~ months ended ~~September 30, 2019~~March 31, 2020 and ~~2018:~~2019:

The amounts recorded in the nine months ended September 30, 2018 included an allocation of share-based compensation related to the share-based awards granted by Fluent to Company employees or non-employees prior to the Spin-off.10

On August 7, 2018, the Company entered into an executive chairman services agreement with Mr. Michael Brauser, the then Executive Chairman of the Company, pursuant to which Mr. Brauser will be providing recommendations on organizational and capital structure, future financing needs and future acquisitions or strategic transactions (“Services Agreement”), for a term of one year, automatically renewing for additional one-year periods unless either party provides written notice to the other of its intent not to renew not fewer than 30 days prior to the expiration of the ~~then current~~then-current term. Mr. Brauser continues to provide services as a consultant under the Services Agreement after his resignation as Executive Chairman and as a member of the board of directors effective on September 9, 2018. Under the Services Agreement, Mr. Brauser receives cash compensation of $30 per month and is entitled to participate in the Company’s incentive compensation plan. The Company recognized consulting service fees relating to the Services Agreement of a total of $90 and ~~$270 during the three and nine months ended September 30, 2019, respectively, and~~ $90 during the three ~~and nine~~ months ended ~~September 30, 2018.~~March 31, 2020 and 2019, respectively. In addition, amortization of share-based compensation expense of ~~$343 and $1,458~~$339 in relation to the RSUs with the 2018 Performance Criteria previously granted to Mr. Brauser was recognized during the three ~~and nine months ended September 30, 2019, respectively.~~

~~Contribution by Fluent represents cash funding provided or the portion of certain expenses allocated by Fluent to red violet, on or prior to the Spin-off.~~

These allocated expenses are primarily corporate employee salaries and benefits of the functional groups (inclusive of executive management, accounting, administrative and information technology) and corporate administrative expenses (inclusive of legal services, accounting and finance services and other corporate and infrastructure services). Corporate employee salaries and benefits were allocated on the basis of time spent, and corporate administrative expenses were allocated on the basis of relative percentage of services utilized or benefit received. red violet recorded expenses of $325 for the three months ended March 31, ~~2018 as a result~~2020. NaN amortization of ~~the allocation of expenses from Fluent. Upon the Spin-off, Fluent no longer allocates any expenses to red violet.~~

~~In addition,~~ share-based compensation ~~of $344, relating to the share-based awards granted by Fluent prior to the Spin-off,~~expense was ~~recorded~~recognized during the three months ended March 31, ~~2018.~~2019.

On January 1, 2019, the Company adopted Leases (Topic 842) using the modified retrospective method applied to all leases existing at the date of initial application. The Company elected the practical expedients to not reassess whether any existing contracts are or contain leases, not reassess the lease classification for any existing leases, and not reassess initial direct costs for any existing leases, upon the adoption of Leases (Topic 842).

The Company leases its corporate headquarters of 21,020 rentable square feet in accordance with a non-cancelable 89-month operating lease agreement as amended and effective in January 2017. The Company also leases an additional office space of 6,003 rentable square feet in accordance with a non-cancellable 90-month operating lease agreement entered into in April 2017, with an option to extend for additional 60 months. The extension option is not included in the determination of the lease term as it is not reasonably certain to be exercised.

For the three ~~and nine~~ months ended ~~September 30,~~March 31, 2020 and 2019, a summary of the Company’s lease information is shown below:

As of ~~September 30, 2019,~~March 31, 2020, the weighted average remaining operating lease term was ~~5.1~~4.6 years.

As of ~~September 30, 2019,~~March 31, 2020, scheduled future maturities and present value of the operating lease liabilities are as follows:

The Company incurred data costs of ~~$1,946~~$2,132 and ~~$1,447~~$1,688 for the three months ended ~~September 30,~~March 31, 2020 and 2019, ~~and 2018, respectively, and $5,501 and $4,080 for the nine months ended September 30, 2019 and 2018,~~ respectively, under certain data licensing agreements. As of ~~September 30, 2019,~~March 31, 2020, material capital commitments under certain data licensing agreements were ~~$16,689,~~$12,766, shown as follows:

On June 21, 2018, the U.S. Supreme Court in South Dakota v. Wayfair, Inc. et al, overturned prior law which required physical presence for nexus and endorsed economic nexus as a basis for South Dakota to require online merchants to collect and remit sales taxes, even if the business does not have an in-state physical presence (the "Wayfair Decision"). As of September 30, 2019, the vast majority of states have enacted or announced their own interpretation of the Wayfair Decision. The Company collects and remits sales tax in certain states as a result of the Wayfair Decision and as a result of its continued overall compliance and review practice related to its sales and use tax obligations. In addition, the Company is currently undergoing a state sales and use tax examination.

The Company establishes accruals for those contingencies where the incurrence of a loss is probable and can be reasonably estimated, and it discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued, if such disclosure is necessary for our financial statements to not be misleading. To estimate whether a loss contingency should be accrued by a charge to income, the Company evaluates, among other factors, the degree of probability of an unfavorable outcome and the ability to make a reasonable estimate of the amount of the loss. The Company does not record liabilities when the likelihood that the liability has been incurred is probable, but the amount cannot be reasonably ~~estimated.~~ estimatedBased upon its analysis of potential sales and use tax labilities, the Company determined that there were no matters that required an accrual as of the balance sheet date, September 30, 2019. The Company estimates that adverse decisions, if any, related to state sales and use tax examinations could result in a possible loss up to $413..

The Company may be involved in litigation from time to time in the ordinary course of business. The Company does not believe that the ultimate resolution of any such matters will have a material adverse effect on its business, financial condition, results of operations or cash flows. However, the results of such matters cannot be predicted with certainty and the Company cannot assure you that the ultimate resolution of any legal or administrative proceeding or dispute will not have a material adverse effect on its business, financial condition, results of operations and cash flows.

In December 2019, a novel strain of coronavirus, now known as Covid-19 (“Covid-19”), was reported in Wuhan, China and has since extensively impacted the global health and economic environment. In March 2020, the World Health Organization characterized Covid-19 as a pandemic. The Company has taken numerous steps, and will continue to take further actions, in its approach to minimizing the impact of the Covid-19 pandemic. As a result of the Covid-19 pandemic, to ensure the health and well-being of our employees, the Company instructed employees at its offices to work from home on a temporary basis. The Company has implemented cost containment strategies across all areas of the organization, including continued curtailment of Company travel and partnering with suppliers, landlords and vendors for price concessions and payment deferrals during this interim period. In the second half of March, as preventative and protective actions were taken by governments, including the implementation of stay-at-home orders, we experienced reduced transactional volume that we believe was a result of customers adjusting to the effects of these stay-at-home orders. Beginning April 1, 2020, the Company elected, under Section 2302 of the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), to defer payment of the employer portion of Social Security payroll tax. Under the CARES Act, employers can forgo timely payment of the employer portion of Social Security taxes that would otherwise be due from March 27, 2020 through December 31, 2020, without penalty or interest charges. Employers must pay 50% of the deferred amount by December 31, 2021, and the remainder by December 31, 2022. The Company will continue to assess the CARES Act and other applicable government-related legislation aimed at assisting businesses during the Covid-19 pandemic. Given the dynamic nature of this health emergency, the full impact of the Covid-19 pandemic on the Company’s ongoing business, results of operations and overall financial performance cannot be reasonably estimated at this time.

On ~~October 28, 2019,~~May 5, 2020, the ~~Company’s compensation committee approved~~Company received funding under a promissory note dated May 5, 2020 (the “Promissory Note”) evidencing an ~~aggregate~~unsecured non-recourse loan in the principal amount of ~~340,500 RSUs~~$2,152 under the CARES Act (the “Loan”). The Loan to ~~certain~~the Company is being made through Legacy Bank of ~~its employees~~Florida (the “Lender”).

The Loan has a two-year term and ~~directors, with a vesting~~matures on May 5, 2022. The interest rate on the Loan is 1.00% per annum. Payments shall be deferred for the first six months of the term of the Loan. The U.S. Small Business Administration has the right to extend the deferment period. The Promissory Note contains customary events of default relating to, among other things, payment defaults, and breach of representations and warranties, or other provisions of the Promissory Note.

The Loan may be forgiven partially or fully if the Loan proceeds are used for covered payroll costs, rent and utility costs incurred during the eight-week period that commenced on the date of ~~3 years, among which 307,500 RSUs~~funding, and at least 75% of the Loan proceeds are ~~also~~used for covered payroll costs. Any forgiveness of the Loan will be subject to approval by the ~~2019 Performance Criteria.~~U.S. Small Business Administration and the Lender. The Company will be required to apply for such forgiveness. Although the Company intends to use the proceeds of the Loan for such covered purposes, it can provide no assurance that the Company will obtain forgiveness of the Loan in whole or in part.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

You should read the following discussion and analysis in conjunction with our condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q (“Form 10-Q”). This Form 10-Q contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (“PSLRA”), Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”), about our expectations, beliefs, or intentions regarding our business, financial condition, results of operations, strategies, or prospects. You can identify forward-looking statements by the fact that these statements do not relate strictly to historical or current matters. Rather, forward-looking statements relate to anticipated or expected events, activities, trends, or results as of the date they are made. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause our actual results to differ materially from any future results expressed or implied by the forward-looking statements. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking ~~statements.~~statements,including the impact of the coronavirus (“Covid-19”) pandemic on our operating results. These factors include those contained in this Quarterly Report on Form 10-Q, as well as the disclosures made in the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2018~~2019 filed on March 7, 12, 2020 (“2019 ~~(“2018~~ Form 10-K”), and other filings we make with the Securities and Exchange Commission. We do not undertake any obligation to update forward-looking statements, except as required by law. We intend that all forward-looking statements be subject to the safe harbor provisions of PSLRA. These forward-looking statements are only predictions and reflect our views as of the date they are made with respect to future events and financial performance. InTo the extent that our business is negatively impacted due to a variety of factors, including the impact of Covid-19 on our operating results, we may implement longer-term cost reduction efforts in order ~~for us~~ to continue to develop new products, grow our existing business and expand into additional markets, we must generate and sustain sufficient operating profits and cash flow in future periods. This will require us to generate additional sales from current products and new products currently under development. We are building out our sales organization to drive current products and to introduce new products into the market place. We will incur increased compensation expenses relating to our sales and marketing, support, administrative, infrastructure, and engineering-related personnel as we increase headcount in the next 12 months.mitigate such impacts.

References in this discussion and analysis to “we,” “us,” “our,” “red violet,” or the “Company,” refer to Red Violet, Inc. and its consolidated subsidiaries.

~~We are~~Red Violet, Inc. (“we,” “us,”“our,” “red violet,”or the “Company”), a Delawarecorporation, is dedicated to making the world a safer place and reducing the cost of doing business. We specialize in ~~big~~ data ~~analysis,~~fusion and analytics, providing cloud-based, mission-critical solutions to enterprises ~~in a variety of industries.~~with use cases including fraud detection, risk mitigation, due diligence and marketing. Through our intelligent platform, CORE^TM, we uncover the relevance of disparate data points utilizing our analytical capabilities to provide real-time and insightful views of people, businesses, assets and their interrelationships.

Leveraging proprietary technology and applying machine learning and advanced ~~analytic~~analytical and decision-making capabilities, CORE provides compelling solutions to public and private sector organizations through intuitive, easy-to-use analytical applications. We empower clients across markets and industries to better execute all aspects of their business, from managing risk, recovering debt, identifying fraud and abuse, and ensuring legislative compliance, to identifying and acquiring customers. With a massive data repository of approximately nine petabytes of public-record, proprietary and publicly-available data, as well as self-reported consumer information and behavioral signals, we transform data into intelligence for our customers to enable better data-driven decisioning.

We presently market our solutions primarily through two brands, idiCORE™, our flagship product, and FOREWARN^®. idiCORE is a next-generation, investigative solution used to address a variety of organizational challenges including due diligence, risk mitigation, identity authentication and legislative compliance, by financial services companies, insurance companies, healthcare companies, law enforcement and government, ~~collection,~~collections, law firms, retail, telecommunication companies, corporate security and investigative firms. FOREWARN is an app-based solution currently tailored for the real estate industry, providing instant knowledge prior to face-to-face engagement with a consumer, helping professionals identify and mitigate risk. As of ~~September 30,~~March 31, 2020 and 2019, idiCORE had ~~over 4,780~~5,326 and 4,020 billable customers and FOREWARN had ~~over 23,850 users.~~36,506 and 15,444 users, respectively. The Company defines a billable customer of idiCORE as a single entity that generated revenue in the last month of the period. Billable customers are typically corporate organizations. In most cases, corporate organizations will have multiple users and/or departments purchasing our solutions, however, the Company counts the entire organization as a discrete customer. The Company defines a user of FOREWARN as a unique person that has a subscription to use the FOREWARN service as of the last day of the period. A unique person can only have one user account.

We generate substantially all of our revenue from licensing our solutions. Customers access our solutions through a hosted environment using an online interface, batch processing, API and custom integrations. We recognize revenue from licensing fees (a) on a transactional basis determined by the customer’s usage, (b) via a monthly fee or (c) from a combination of both. Revenue pursuant to pricing contracts containing a monthly fee is recognized ratably over the contract period. Pricing contracts are generally annual contracts or longer, with auto renewal. Revenue from pricing contracts represented ~~66%~~69% and ~~65%~~67% of total revenue for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2020 and 2019, respectively.

Our go-to-market strategy leverages (a) an inside sales team that cultivates relationships, and ultimately closes business, with their end-user markets, (b) a strategic sales team that provides a more personal, face-to-face approach for major accounts within certain industries, and (c) distributors, resellers, and strategic partners that have a significant foothold in many of the industries that we have not historically served, as well as to further penetrate those industries that we do serve. Our sales model generally begins with a free trial followed by an initial purchase on a transactional basis or minimum-committed monthly spend. As organizations derive benefits from our solutions, we are able to “land and expand” within larger organizations as additional use cases expand across departments, divisions and geographic locations and customers become increasingly reliant on our solutions in their daily workflow.

OnIn order for us to continue to develop new products, grow our existing business and expand into additional markets, we must generate and sustain sufficient operating profits and cash flow in future periods. This will require us to generate additional sales from current products and new products currently under development. We continue to build out our sales organization to drive current products and to introduce new products into the marketplace.

In December 2019, a novel strain of coronavirus, now known as Covid-19, was reported in Wuhan, China and has since extensively impacted the global health and economic environment. In March ~~26, 2018, Fluent, Inc. (“Fluent”) spun off~~2020, the World Health Organization characterized Covid-19 as a pandemic. The Company has taken numerous steps, and will continue to take further actions, in its ~~risk management business by way of a distribution of all~~approach to minimizing the impact of the ~~shares of common stock of its then wholly-owned subsidiary, red violet, to its stockholders as~~Covid-19 pandemic. As a result of the ~~record date~~Covid-19 pandemic, to ensure the health and ~~certain warrant holders (the “Spin-off”). Upon~~well-being of our employees, the ~~Spin-off, red violet owned Fluent subsidiaries~~Company instructed employees at its offices to work from home on a temporary basis. The Company has implemented cost containment strategies across all areas of the organization, including continued curtailment of Company travel and partnering with suppliers, landlords and vendors for price concessions and payment deferrals during this interim period. In the second half of March, as preventative and protective actions were taken by governments, including the implementation of stay-at-home orders, we experienced reduced transactional volume that ~~previously operated Fluent’s risk management business, and red violet became an independent public company. For periods prior~~we believe was a result of customers adjusting to the ~~Spin-off,~~effects of these ~~financial statements were prepared on a consolidated and combined basis because certain~~stay-at-home orders. Beginning April 1, 2020, the Company elected, under Section 2302 of the ~~entities were under common control.~~Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), to defer payment of the employer portion of Social Security payroll tax. Under the CARES Act, employers can forgo timely payment of the employer portion of Social Security taxes that would otherwise be due from March 27, 2020 through December 31, 2020, without penalty or interest charges. Employers must pay 50% of the deferred amount by December 31, 2021, and the remainder by December 31, 2022. The Company will continue to assess the CARES Act and other applicable government-related legislation aimed at assisting businesses during the Covid-19 pandemic. Given the dynamic nature of this health emergency, the full impact of the Covid-19 pandemic on the Company’s ongoing business, results of operations and overall financial performance cannot be reasonably estimated at this time.

Management’s discussion and analysis of financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”). The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to the allowance for doubtful accounts, useful lives of property and equipment and intangible assets, recoverability of the carrying amounts of goodwill and intangible assets, share-based compensation and income tax provision. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

For additional information, please refer to our ~~2018~~2019 Form 10-K. There have been no material changes to Critical Accounting Policies and Estimates disclosed in our ~~2018~~2019 Form 10-K.

See Note 1(b), “Recently issued accounting standards,” in “Notes to Condensed Consolidated Financial Statements.”

For the three months ended ~~September 30, 2019~~March 31, 2020 as compared to the three months ended ~~September 30, 2018:~~March 31, 2019:

Management evaluates the financial performance of our business on a variety of key indicators, including non-GAAP metrics of adjusted EBITDA, adjusted gross profit and adjusted gross margin. Adjusted EBITDA is a financial measure equal to net loss, the most directly comparable financial measure based on US GAAP, excluding interest income, net, depreciation and amortization, share-based compensation expense, litigation costs, net, ~~transition service income,~~ and write-off of long-lived assets and others, as noted in the tables below. We define adjusted gross profit as revenue less cost of revenue (exclusive of depreciation and amortization), and adjusted gross margin as adjusted gross profit as a percentage of revenue.

	Three Months Ended September 30,						Nine Months Ended September 30,						Three Months Ended March 31,
(In thousands)	2019			2018			2019			2018			2020			2019
Net loss	$	(992	)	$	(1,252	)	$	(6,220	)	$	(4,830	)	$	(1,481	)	$	(1,378	)
Interest income, net		(46	)		(31	)		(123	)		(31	)		(31	)		(40	)
Depreciation and amortization		750			508			2,049			1,437			910			618
Share-based compensation expense		1,407			218			5,290			432			2,221			274
Litigation costs, net		7			125			54			134			-			94
Insurance proceeds in relation to settled litigation		-			(350	)		-			(350	)
Transition service income		-			(56	)		-			(214	)
Write-off of long-lived assets and others		11			2			41			92			111			30
Adjusted EBITDA	$	1,137		$	(836	)	$	1,091		$	(3,330	)	$	1,730		$	(402	)

	Three Months Ended September 30,						Nine Months Ended September 30,
(In thousands)	2019			2018			2019			2018
Revenue	$	8,257		$	4,360		$	21,236		$	11,594
Cost of revenue (exclusive of depreciation and amortization)		3,122			2,233			8,843			6,334
Adjusted gross profit	$	5,135		$	2,127		$	12,393		$	5,260
Adjusted gross margin		62	%		49	%		58	%		45	%

WeThe following is a reconciliation of gross profit, the most directly comparable GAAP financial measure, to adjusted gross profit:

In order to assist readers of our condensed consolidated financial statements in understanding the operating results that management uses to evaluate the business and for financial planning purposes, we present non-GAAP measures of adjusted EBITDA, adjusted gross profit and adjusted gross margin as supplemental measures of our operating ~~performance because we~~performance. We believe they provide useful information to our investors as they eliminate the impact of certain items that we do not consider indicative of our cash operations and ongoing operating performance. In addition, we use them as an integral part of our internal reporting to measure the performance ~~of our business, evaluate the performance of our senior management~~ and ~~measure the~~ operating strength of our business.

We believe adjusted EBITDA, adjusted gross profit and adjusted gross margin are ~~measures~~relevant and provide useful information frequently used by securities analysts, investors and other interested parties in their evaluation of the operating performance of companies similar to ours and are indicators of the operational strength of our business. ~~Adjusted~~We believe adjusted EBITDA eliminates the uneven effect of considerable amounts of non-cash depreciation and amortization, share-based compensation expense and the impact of other ~~items. Adjusted~~non-recurring items, providing useful comparisons versus prior periods or forecasts. Our adjusted gross profit is a measure used by management in evaluating the business’s current operating performance by excluding the impact of prior historical costs of assets that are expensed systematically and allocated over the estimated useful lives of the assets, which may not be indicative of the current operating activity. Our adjusted gross ~~margin are~~profit is calculated by using revenue, less cost of revenue (exclusive of depreciation and amortization). We believe adjusted gross profit provides useful information to our investors by eliminating the impact of non-cash depreciation and amortization, and specifically the amortization of software developed for internal use, providing a baseline of our core operating results that allow for analyzing trends in our underlying business consistently over multiple periods. Adjusted gross margin is calculated as adjusted gross profit as a percentage of revenue.

Adjusted EBITDA, adjusted gross profit and adjusted gross margin are not intended to be performance measures that should be regarded as an alternative to, or more meaningful than, ~~either loss before income taxes or net loss as indicators of operating performance or to cash flows from operating activities as a measure of liquidity.~~financial measures presented in accordance with GAAP. The way we measure adjusted EBITDA, adjusted gross profit and adjusted gross margin may not be comparable to similarly titled measures presented by other companies, and may not be identical to corresponding measures used in our various agreements.

Three months ended ~~September 30, 2019~~March 31, 2020 compared to three months ended ~~September 30, 2018~~March 31, 2019

Revenue. Revenue increased ~~$3.9~~$3.6 million or ~~89%~~62% to ~~$8.3~~$9.3 million for the three months ended ~~September 30, 2019~~March 31, 2020 from ~~$4.4~~$5.7 million for the three months ended ~~September 30, 2018.~~March 31, 2019. This increase was driven by strong growth in ~~volume from onboarding of new customers and~~ usage from existing customers. Revenue from new customers increased $0.2 million or 10%, base revenue from existing customers increased $3.0 million or 84%, and growth revenue from existing customers increased $0.4 million or 46% for the three months ended March 31, 2020 compared to the three months ended March 31, 2019, respectively. Our idiCORE billable customer base grew from ~~approximately 3,430~~4,020 customers as of ~~September 30, 2018~~March 31, 2019 to ~~4,780~~5,326 customers as of ~~September 30, 2019.~~March 31, 2020. Revenue from new customers represents the total monthly revenue generated from new customers in a given period. A customer is defined as a new customer during the first six months of revenue generation. Base revenue from existing customers represents the total monthly revenue generated from existing customers in a given period that does not exceed the customers' trailing six-month average revenue. A customer is defined as an existing customer six months after their initial month of revenue. Growth revenue from existing customers represents the total monthly revenue generated from existing customers in a given period in excess of the customers' trailing six-month average revenue.

Cost of revenue (exclusive of depreciation and amortization). Cost of revenue increased ~~$0.9~~$0.6 million or ~~40%~~23% to ~~$3.1~~$3.3 million for the three months ended ~~September 30, 2019~~March 31, 2020 from ~~$2.2~~$2.7 million for the three months ended ~~September 30, 2018.~~March 31, 2019. Our cost of revenue primarily includes data acquisition costs. Data acquisition costs consist primarily of the costs to acquire data either on a transactional basis or through flat-fee data licensing agreements, including unlimited usage agreements. We continue to enhance the breadth and depth of our data through the addition and expansion of relationships with key data suppliers, including our largest data supplier, which accounted for approximately ~~40%~~39% of our total data acquisition costs for the three months ended ~~September 30, 2019~~March 31, 2020 compared to approximately ~~44%~~41% for the three months ended ~~September 30, 2018.~~March 31, 2019. Other cost of revenue items include expenses related to third-party infrastructure fees.

As the construct of our data costs is primarily a flat-fee, unlimited usage model, the cost of revenue as a percentage of revenue decreased to ~~38%~~35% for the three months ended ~~September 30, 2019~~March 31, 2020 from ~~51%~~47% for the three months ended ~~September 30, 2018.~~March 31, 2019. We expect that cost of revenue as a percentage of revenue will continue to decrease over the coming years as our revenue increases. Historically, at scale, the industry business model’s cost of revenue will trend between 15% and 30% as a percentage of revenue.

Sales and marketing expenses. Sales and marketing expenses increased ~~$0.8~~$0.7 million or ~~71%~~45% to ~~$1.9~~$2.2 million for the three months ended ~~September 30, 2019~~March 31, 2020 from ~~$1.1~~$1.5 million for the three months ended ~~September 30, 2018.~~March 31, 2019. Sales and marketing expenses consist of salaries and benefits, advertising and marketing, ~~traveling~~travel expenses, and share-based compensation expense, incurred by our sales team, and provision for bad debts. The increase induring the three months ended ~~September 30, 2019~~March 31, 2020 was primarily attributable to ~~the~~an aggregate of $0.5 million increase in salaries and benefits, ~~resulting from increased headcount~~ as we continue to invest in the expansion of our sales ~~organization.~~organization, and sales commissions from increased revenue.

General and administrative expenses. General and administrative expenses increased ~~$1.3~~$2.0 million or ~~60%~~87% to ~~$3.5~~$4.4 million for the three months ended ~~September 30, 2019~~March 31, 2020 from ~~$2.2~~$2.4 million for the three months ended ~~September 30, 2018.~~ March 31, 2019. The increase during the three months ended March 31, 2020 was primarily attributable to the $1.9 million increase in share-based compensation expense, resulting from the achievement of certain performance-based milestones and certain new grants issued after the first quarter of 2019, as outlined in Note 8, “Share-based compensation,” included in “Notes to Condensed Consolidated Financial Statements.”

For the three months ended ~~September 30,~~March 31, 2020 and 2019, ~~and 2018,~~ our general and administrative expenses consisted primarily of employee salaries and benefits of ~~$1.1~~$1.2 million and ~~$0.9~~$1.0 million, share-based compensation expense of ~~$1.3~~$2.1 million and $0.2 million, and professional fees of $0.6 million and $0.7 million, respectively. The increase in share-based compensation expense was as a result of achieving certain performance-based milestones and certain new grants. See Note 8, “Share-based compensation,” included in “Notes to Condensed Consolidated Financial Statements,” for details.

Depreciation and amortization. Depreciation and amortization expenses increased $0.3 million or ~~48%~~47% to ~~$0.8~~$0.9 million for the three months ended ~~September 30, 2019~~March 31, 2020 from ~~$0.5~~$0.6 million for the three months ended ~~September 30, 2018.~~March 31, 2019. The increase in depreciation and amortization for the three months ended ~~September 30, 2019~~March 31, 2020 resulted primarily from the amortization of software developed for internal use that became ready for its intended use after ~~the third quarter of 2018.~~March 31, 2019.

Loss before income taxes. We had a loss before income taxes of ~~$1.0~~$1.5 million for the three months ended ~~September 30, 2019~~March 31, 2020 as compared to ~~$1.3~~$1.4 million for the three months ended ~~September 30, 2018.~~March 31, 2019. The ~~decrease~~slight increase in loss before income taxes was primarily attributable to the increase in ~~revenue and the decrease in our cost of revenue as a percentage of revenue, which was partially offset by the increase in share-based compensation expense and employee salaries and benefits.~~

~~Income taxes~~. Income tax expense of $0 was recognized for three months ended September 30, 2019 and 2018. A full valuation allowance on the deferred tax assets was recognized as of September 30, 2019 and 2018. See Note 6, “Income Taxes,” included in “Notes to Condensed Consolidated Financial Statements,” for details.

~~Net loss. A net loss of $1.0 million was recognized for the three months ended September 30, 2019 as compared to $1.3 million for the three months ended September 30, 2018, as a result of the foregoing~~.

~~Nine months ended September 30, 2019 compared to nine months ended September 30, 2018~~

~~Revenue~~. Revenue increased $9.6 million or 83% to $21.2 million for the nine months ended September 30, 2019 from $11.6 million for the nine months ended September 30, 2018. This increase was driven by strong growth in volume from onboarding of new customers and usage from existing customers. Our idiCORE billable customer base grew from approximately 3,430 customers as of September 30, 2018 to 4,780 customers as of September 30, 2019.

~~Cost of revenue (exclusive of depreciation and amortization). Cost of revenue increased $2.5 million or 40% to $8.8 million for the nine months ended September 30, 2019 from $6.3 million for the nine months ended September 30, 2018. Our~~ cost of revenue primarily includes data acquisition costs. Data acquisition costs consist primarily of the costs to acquire data either on a transactional basis or through flat-fee data licensing agreements, including unlimited usage agreements. We continue to enhance the breadth and depth of our data through the addition and expansion of relationships with key data suppliers, including our largest data supplier, which accounted for approximately 41% of our total data acquisition costs for the nine months ended September 30, 2019 compared to approximately 47% for the nine months ended September 30, 2018. Other cost of revenue items include expenses related to third-party infrastructure ~~fees.~~

As the construct of our data costs is primarily a flat-fee, unlimited usage model, the cost of revenue as a percentage of revenue decreased to 42% for the nine months ended September 30, 2019 from 55% for the nine months ended September 30, 2018. We expect that cost of revenue as a percentage of revenue will continue to decrease over the coming years as our revenue increases. Historically, at scale, the industry business model’s cost of revenue will trend between 15% and 30% as a percentage of revenue.

~~Sales and marketing expenses~~. Sales and marketing expenses increased $2.0 million or 58% to $5.4 million for the nine months ended September 30, 2019 from $3.4 million for the nine months ended September 30, 2018. Sales and marketing expenses consist of salaries and benefits, advertising and marketing, traveling expenses, and share-based compensation expense, incurred by our sales team, and provision for bad debts. The increase in the nine months ended September 30, 2019 was primarily attributable to the increase in salaries and benefits resulting from increased headcount as we continue to invest in the expansion of our sales organization, and the increase in share-based compensation expense and provision for bad debts.

~~General and administrative expenses~~. General and administrative expenses increased $5.5 million or 95% to $11.3 million for the nine months ended September 30, 2019 from $5.8 million for the nine months ended September 30, 2018. For the nine months ended September 30, 2019 and 2018, our general and administrative expenses consisted primarily of employee salaries and benefits of $3.1 million and $2.4 million,noncash share-based compensation expense of ~~$5.0~~$1.9 million, ~~(including a one-time $1.3~~salaries and benefits and sales commission of $0.7 million, ~~as a result of achieving certain performance-based milestones~~) and $0.3 million, and professional fees of $1.8 million and $1.8 million, respectively. The increase in share-based compensation expense was as a result of achieving certain performance-based milestones and certain new grants. See Note 8, “Share-based compensation,” included in “Notes to Condensed Consolidated Financial Statements,” for details.

~~Depreciation and amortization~~. Depreciation and amortization expenses increased $0.6 million or 43% to $2.0 million for the nine months ended September 30, 2019 from $1.4 million for the nine months ended September 30, 2018. The increase in depreciation and amortization ~~for the nine months ended September 30, 2019 resulted from the amortization~~ of ~~software developed for internal use that became ready for its intended use after the third quarter of 2018.~~

~~Loss before income taxes. We~~ ~~had a loss before income taxes of~~ ~~$6.2~~$0.3 million, for the nine months ended September 30, 2019 as compared to $4.8 million for the nine months ended September 30, 2018. The increase in loss before income taxes was primarily attributable to the recognition of share-based compensation expense of $5.3 million ($1.3 million of which is one-time), which was partially offset by the increase in revenue and the decrease in our cost of revenue as a percentage of revenue.

Income taxes. Income tax expense of $0 was recognized for ~~nine~~the three months ended ~~September 30, 2019~~March 31, 2020 and ~~2018.~~2019. A full valuation allowance on the deferred tax assets was recognized as of ~~September 30, 2019~~March 31, 2020 and ~~2018.~~2019. See Note 6, “Income Taxes,” included in “Notes to Condensed Consolidated Financial Statements,” for details.

Net loss. A net loss of ~~$6.2~~$1.5 million was recognized for the ~~nine~~three months ended ~~September 30, 2019~~March 31, 2020 as compared to ~~$4.8~~$1.4 million for the ~~nine~~three months ended ~~September 30, 2018,~~March 31, 2019, as a result of the foregoing.

The rates of inflation experienced in recent years have had no material impact on our financial statements. We attempt to recover increased costs by increasing prices for our services, to the extent permitted by contracts and competition.

Cash flows provided by (used in) operating activities. For the ~~nine~~three months ended ~~September 30, 2019,~~March 31, 2020, net cash provided by operating activities was ~~$0.4~~$1.2 million, primarily the result of the net loss of ~~$6.2~~$1.5 million, adjusted for certain non-cash items (consisting of share-based compensation expense, depreciation and amortization, write-off of long-lived assets, provision for bad debts and noncash lease expenses) totaling ~~$8.1~~$3.4 million, and the cash used as a result of changes in assets and liabilities of ~~$1.4~~$0.7 million, primarily the result of the increase in ~~accounts receivable, following~~prepaid expenses and other current assets and the ~~increase~~decrease in ~~revenue.~~accrued expenses and other current liabilities. For the ~~nine~~three months ended ~~September 30, 2018,~~March 31, 2019, net cash used in operating activities was ~~$6.8~~$1.2 million, primarily the result of the net loss of ~~$4.8~~$1.4 million, adjusted for certain non-cash items, ~~of an aggregate of $2.5~~as mentioned above, totaling $1.2 million, and the cash used as a result of changes in assets and liabilities of ~~$4.8~~$1.0 million, primarily the result of the increase in accounts receivable and ~~the decrease in accrued~~prepaid expenses and other current ~~liabilities.~~assets.

Cash flows used in investing activities. ~~Net~~For the three months ended March 31, 2020 and 2019, net cash used in investing activities ~~for the nine months ended September 30, 2019~~was $1.6 million and ~~2018 was $4.5~~$1.4 million, respectively, primarily as a result of capitalized costs included in intangible assets ~~for the corresponding periods.~~

~~Cash flows provided by financing activities. Net cash provided by financing activities for the nine months ended September 30, 2019 was $7.4~~of $1.5 million ~~as a result of the registered direct offering in August 2019. Net cash provided by financing activities for the nine months ended September 30, 2018 was $23.9~~and $1.4 million, ~~(inclusive of the $20.0 million cash contribution by Fluent to red violet upon the Spin-off) as a result of capital contributed by Fluent.~~respectively.

As of ~~September 30, 2019,~~March 31, 2020, we had material commitments under certain data licensing agreements of ~~$16.7~~$12.8 million. We anticipate funding our operations using available cash and cash flow generated from operations within the next twelve months.

We reported net loss of ~~$1.0~~$1.5 million and ~~$1.3~~$1.4 million for the three months ended ~~September 30,~~March 31, 2020 and 2019, ~~and 2018, respectively, and $6.2 million and $4.8 million for the nine months ended September 30, 2019 and 2018,~~ respectively. As of ~~September 30, 2019,~~March 31, 2020, we had a total shareholders’ equity balance of ~~$42.1~~$43.4 million.

As of ~~September 30, 2019,~~March 31, 2020, we had cash and cash equivalents of approximately ~~$13.3~~$11.5 million. Based on projections of growth in revenue and operating results in the next twelve months, ~~and~~ the available cash and cash equivalents held by us, and an unsecured non-recourse loan in the principal amount of approximately $2.2 million under the CARES Act, we believe that we will have sufficient cash resources to finance our operations and expected capital expenditures for the next twelve months. ~~Subject~~

We further believe that our financial resources, including the CARES Act loan, will allow us to manage the impact of Covid-19 on the Company's business operations for the foreseeable future. However, subject to revenue growth, our ability to generate positive cash flow, and the potential impact of Covid-19, we may have to raise capital through the issuance of additional equity and/or debt, which, if we are able to obtain, could have the effect of diluting stockholders. Any equity or debt financings, if available at all, may be on terms which are not favorable to us. If our operations do not generate positive cash flow in the upcoming year, or if we are not able to obtain additional equity or debt financing on terms and conditions acceptable to us, if at all, we may be unable to implement our business plan, or even continue our operations.

As of ~~September 30, 2019,~~March 31, 2020, we did not have any off-balance sheet arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K.

As a smaller reporting company as defined in Rule 12b-2 of the Exchange Act, we are not required to include information required by this item.

Our management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d–15(e) of the Exchange Act) as of ~~September 30, 2019.~~March 31, 2020. We maintain disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure.

Based on the evaluation of disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act), the Company’s Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of ~~September 30, 2019.~~March 31, 2020.

There were no changes in the Company’s internal control over financial reporting identified in connection with management's evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act during the ~~last~~ fiscal quarter ~~of 2019~~ended March 31, 2020 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures and Internal Control over Financial Reporting

In designing and evaluating the disclosure controls and procedures and internal control over financial reporting, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures and internal control over financial reporting must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

The Company is not currently a party to any legal proceeding, investigation or claim which, in the opinion of the management, is likely to have a material adverse effect on the business, financial condition, results of operations or cash flows. Legal fees associated with any legal proceedings, are expensed as incurred. We review legal proceedings and claims on an ongoing basis and follow appropriate accounting guidance, including ASC 450, when making accrual and disclosure decisions. We establish accruals for those contingencies where the incurrence of a loss is probable and can be reasonably estimated, and we disclose the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued, if such disclosure is necessary for our financial statements to not be misleading. To estimate whether a loss contingency should be accrued by a charge to income, we evaluate, among other factors, the degree of probability of an unfavorable outcome and the ability to make a reasonable estimate of the amount of the loss. We do not record liabilities when the likelihood that the liability has been incurred is probable, but the amount cannot be reasonably estimated.

We may be involved in litigation from time to time in the ordinary course of business. We do not believe that the ultimate resolution of any such matters will have a material adverse effect on our business, financial condition, results of operations or cash flows. However, the results of such matters cannot be predicted with certainty and we cannot assure you that the ultimate resolution of any legal or administrative proceeding or dispute will not have a material adverse effect on our business, financial condition, results of operations and cash flows.

There ~~have been~~were no material changes during the first quarter of 2020 to the risk factors ~~previously disclosed~~identified in the Company’s ~~Annual Report on~~2019 Form 10-K, except as noted below.

The current Covid-19 pandemic and the global attempt to contain it may adversely impact our business, our future results of operations and our overall financial performance.

The global spread of Covid-19 and the various attempts to contain it have created significant volatility, uncertainty and economic disruption. In response to government mandates and health care advisories, we have altered certain aspects of our operations. Our workforce has had to spend a significant amount of time working from home, which may impact productivity, and we have curtailed all company travel to ensure the safety of our employees, customers, vendors, and shareholders. To the extent the resulting economic disruption is severe, we could see some vendors and customers negatively impacted.

The full extent to which the Covid-19 pandemic and the various responses to it impacts our business, operations and financial results will depend on numerous evolving factors that we may not be able to accurately predict, including: the duration and scope of the pandemic; governmental, business and individuals’ actions that have been and continue to be taken in response to the pandemic; the availability and cost to access the capital markets; the effect on our customers and customer demand for and ability to pay for our services; and disruptions or restrictions on our employees’ ability to work and travel. In addition, any preventative or protective actions that governments implement or that we take in respect of Covid-19, such as travel restrictions or stay-at-home orders, may interfere with the ability of our employees and vendors to perform their respective responsibilities and obligations relative to the conduct of our business. Such results could have a material adverse effect on our operations, business, financial condition, results of operations, or cash flows.

We are closely monitoring the impact of the Covid-19 pandemic, continually assessing its potential effects on our business. The extent to which our results are affected by Covid-19 will largely depend on future developments which cannot be accurately predicted and are uncertain, but the Covid-19 pandemic or the perception of its effects could have a material adverse effect on our business, financial condition, results of operations, or cash flows.

Our CARES Act Loan may be subject to regulatory review resulting from unclear subjective and objective eligibility requirements for the ~~year ended December 31, 2018 filed~~loan.

On May 5, 2020, we received funding of $2,152,000 under the CARES Act Loan. The Loan application required us to certify, among other things, that the current economic uncertainty made the Loan request necessary to support our ongoing operations. While we made this certification in good faith after analyzing, among other things, our financial situation and access to alternative forms of capital, and believe that we satisfied all eligibility criteria for the Loan, the certification described above does not contain any objective criteria and is subject to interpretation. If, despite our good faith belief that we satisfied all eligibility requirements for the Loan, we are found to have been ineligible to receive the Loan or in violation of any of the laws or governmental regulations that apply to us in connection with the ~~Securities~~Loan, we may be subject to penalties, including significant civil, criminal and ~~Exchange Commission on March 7, 2019.~~administrative penalties and could be required to repay the Loan. In the event that we seek forgiveness of all or a portion of the Loan, we will also be required to make certain certifications which will be subject to audit and review by governmental entities and could subject us to significant penalties and liabilities if found to be inaccurate. In addition, our receipt of the Loan may result in adverse publicity and damage to our reputation, and a review or audit by a government entity could consume significant financial and management resources. Any of these events could harm our business, results of operations and financial condition.

On ~~November 4, 2019, Jacky Wang notified~~May 5, 2020, the ~~board~~Company received funding under a promissory note dated May 5, 2020 (the “Promissory Note”) evidencing an unsecured non-recourse loan in the principal amount of ~~directors of his intention to resign as Principal Accounting Officer on November 4, 2019. His departure is not due to any disagreement related~~$2,152,000 under the CARES Act (the “Loan”). The Loan to the ~~Company’s operations, financial statements, internal controls, auditors, policies~~Company is being made through Legacy Bank of Florida (the “Lender”).

The Loan has a two-year term and matures on May 5, 2022. The interest rate on the Loan is 1.00% per annum. Payments shall be deferred for the first six months of the term of the Loan. The U.S. Small Business Administration has the right to extend the deferment period. The Promissory Note contains customary events of default relating to, among other things, payment defaults, and breach of representations and warranties, or ~~practices. Mr. Wang~~other provisions of the Promissory Note.

The Loan may be forgiven partially or fully if the Loan proceeds are used for covered payroll costs, rent and utility costs incurred during the eight-week period that commenced on the date of funding, and at least 75% of the Loan proceeds are used for covered payroll costs. Any forgiveness of the Loan will ~~remain with~~be subject to approval by the U.S. Small Business Administration and the Lender. The Company will be required to apply for such forgiveness. Although the Company ~~as a principal accounting advisor.~~intends to use the proceeds of the Loan for such covered purposes, it can provide no assurance that the Company will obtain forgiveness of the Loan in whole or in part.

~~On November 4, 2019,~~The foregoing description of the board of directors appointed Daniel MacLachlan, the Company’s current Chief Financial Officer and Principal Financial Officer, as Principal Accounting Officer. The information called for by Item 5.02(c) of Form 8-K is included in the Company’s proxy statement for its ~~2019 Annual Meeting of Stockholders~~Promissory Note does not purport to be complete and is qualified in its entirety by reference to the full text of the Promissory Note attached to this Form 10-Q as Exhibit 10.1 and incorporated herein by reference.

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

Incorporated by Reference

Filed
Exhibit No.

Exhibit Description

Form

File No.

Exhibit

Filing Date

Herewith
10.1

Securities Purchase Agreement, dated as of August 28, 2019.

8-K

0001-38407

10.1

08/28/2019

31.1

Certification of Chief Executive Officer filed pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a) of the Securities and Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

X
31.2

Certification of Chief Financial Officer filed pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a) of the Securities and Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

X
32.1*

Certification by Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

X
32.2*

Certification by Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

X
101.SCH

Inline XBRL Taxonomy Extension Schema Document.

X
101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

X
101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document.

X
101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document.

X
101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document.

X
104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

*

This certification is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended (Exchange Act), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended or the Exchange Act.

Incorporated by Reference

Filed

Exhibit No.

Exhibit Description

Form

File No.

Exhibit

Filing Date

Herewith

10.1

Promissory Note dated May 5, 2020, by and between Red Violet, Inc. and Legacy Bank of Florida.

31.1

Certification of Chief Executive Officer filed pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a) of the Securities and Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2

Certification of Chief Financial Officer filed pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a) of the Securities and Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*

Certification by Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2*

Certification by Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH

Inline XBRL Taxonomy Extension Schema Document.

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document.

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

This certification is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended (Exchange Act), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended or the Exchange Act.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Delaware		82-2408531
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification No.)


Title of each class	Trading Symbol (s)	Name of each exchange on which registered
Common Stock, $0.001 par value per share	RDVT	The NASDAQ Stock Market LLC

		Page
PART I - FINANCIAL INFORMATION

Item 1.	Financial Statements (unaudited)
	Condensed consolidated balance sheets as of ~~September 30, 2019~~March 31, 2020 and December 31, ~~2018~~2019	2
	Condensed consolidated statements of operations for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2020 and 2019 ~~and 2018~~	3
	Condensed consolidated statements of changes in shareholders' equity ~~and member’s capital~~ for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2020 and 2019 ~~and 2018~~	4
	Condensed consolidated statements of cash flows for the ~~nine~~three months ended ~~September 30,~~March 31, 2020 and 2019 ~~and 2018~~	5
	Notes to condensed consolidated financial statements	6
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	1514
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	2119
Item 4.	Controls and Procedures	2119

PART II - OTHER INFORMATION

Item 1.	Legal Proceedings	2220
Item 1A.	Risk Factors	2220
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	2221
Item 3.	Defaults Upon Senior Securities	2221
Item 4.	Mine Safety Disclosures	2221
Item 5.	Other Information	2221
Item 6.	Exhibits	2322

SIGNATURES		2423

(In thousands)
Year	September 30, 2019		March 31, 2020
Remainder of 2019	$	714
2020		3,446
Remainder of 2020			$	2,832
2021		3,642		4,324
2022		3,640		4,321
2023		3,565		4,245
2024 and thereafter		8,043
2024				3,629
2025 and thereafter				5,959
Total	$	23,050	$	25,310

	Number of units			Weighted average grant-date fair value
Unvested as of December 31, 2018 ⁽¹⁾		2,121,000		$	7.65
Granted ⁽¹⁾⁽²⁾		577,000		$	10.12
Vested and delivered		(582,902	)	$	7.63
Withheld as treasury stock⁽³⁾		(103,147	)	$	7.75
Vested not delivered		(12,250	)	$	6.13
Forfeited		(44,791	)	$	7.50
Unvested as of September 30, 2019		1,954,910		$	8.39

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

	Three Months Ended March 31,
(In thousands, except share data)	2020			2019
Numerator:
Net loss	$	(1,481	)	$	(1,378	)
Denominator:
Weighted average shares outstanding - Basic and diluted ⁽¹⁾		11,583,214			10,267,680
Loss per share:
Basic and diluted:	$	(0.13	)	$	(0.13	)

	Number of units			Weighted average grant-date fair value
Unvested as of December 31, 2019		2,237,827		$	8.88
Vested and delivered		(35,250	)	$	7.25
Vested not delivered		(12,000	)	$	6.10
Forfeited		(5,000	)	$	7.25
Unvested as of March 31, 2020		2,185,577		$	8.92

	Three Months Ended		Nine Months Ended			Three Months Ended March 31,
(In thousands)	September 30, 2019		September 30, 2019			2020		2019
Lease cost:
Operating lease costs	$	168	$	504		$	168	$	168
Other information:
Cash paid for operating leases	$	172	$	513		$	174	$	170
Right-of-use assets obtained in exchange for operating lease liabilities	$	-	$	3,042		$	-	$	3,042
Weighted average discount rate for operating leases ⁽¹⁾		-		8.0	%		-		8.0	%

May 11, 2020		Red Violet, Inc.
~~November 7, 2019~~
	By:	/s/ Daniel MacLachlan
		Daniel MacLachlan
		Chief Financial Officer
		(Principal Financial and Accounting Officer)